Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 54 min ago
Peer-reviewedCC BYOpen Medicine

Molecular insights into drug repurposing and drug target proteins identification for Yersinia enterocolitica

  • Kanwal Munazza1
  • Bilal Muhammad2
  • Faheem Muhammad3
  • Awan Uzma Azeem1
  • El Hadi Mohamed Rania Ali4
  • Alwethaynani Maher S.5
  • Binsaleh Ammena Y.6
  • Fallatah Deema7
  • Alghamdi Abeer M8
  • Aziz Tariq9
  • Jamal Syed Babar1
9 affiliations
  1. 1Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan
  2. 2Department of Biological Sciences, Oakland University, Michigan, USA
  3. 3Department of Gastroenterology, Mayo Clinic, Jacksonville, FL, USA
  4. 4Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh 11671, Riyadh, Saudi Arabia
  5. 5Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Riyadh, Saudi Arabia
  6. 6Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh 11671, Riyadh, Saudi Arabia
  7. 7Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia
  8. 8Department of Biology, Faculty of Science, Al-Baha University, Al-Baha, Saudi Arabia
  9. 9Molecular Microbiology and Infectious Diseases Research Center, University of Tabuk, 71491, Tabuk, Saudi Arabia
Read full textDOICite

Abstract

Infectious diseases caused by bacteria such as Yersinia enterocolitica pose significant global health challenges. Y. enterocolitica, a Gram-negative bacterium, is known for causing gastrointestinal diseases in humans. The objective of this study was to identify potential drug targets to combat Y. enterocolitica infections.

Related

  1. Identification of CRF-related molecular subtypes and a prognostic CRRS model in glioma: insights into immunotherapy response prediction and candidate biomarkers
    Jihao Xue, Jianguo Xu, Qijia Yin +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Human geneticsCrossref
  2. Identification of two pathogenic guanidinoacetate methyltransferase variants in patients with intellectual disability: clinical and molecular insights
    Seyyed Reza Hashemi, AbdolAzim Nejatizadeh, Mohammad Hasan Sheikhha +5
    Molecular Genetics and Metabolism ReportsPeer-reviewedCC BY 4.0Full textGeneral medicinePMCEurope PMC
  3. Identification of hepatitis B virus-associated membrane proteins as prognostic biomarkers for hepatocellular carcinoma based on retrospective analysis of integrated membrane proteomics
    Zichen Liu, Jiaming Wan, Guoli Deng +5
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Molecular chaperone-like TIGR04500 family proteins guide graspetide biosynthesis
    Ling Hu, Wei Huang, Jiwu Huang +5
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textPharmacology & toxicologyCrossref
  5. Functional insights into long non-coding and circular RNAs afforded by studying their endogenous interactions with proteins
    Marta Sztachera, Marcin Kolinski, Monika Piwecka
    Cellular and Molecular Life SciencesPeer-reviewedCC BYFull textOncologyDOAJ

Cite

BibTeXRIS
BibTeX
@article{munazza2026molecular,
  title = {{Molecular insights into drug repurposing and drug target proteins identification for Yersinia enterocolitica}},
  author = {Kanwal Munazza and Bilal Muhammad and Faheem Muhammad and Awan Uzma Azeem and El Hadi Mohamed Rania Ali and Alwethaynani Maher S. and Binsaleh Ammena Y. and Fallatah Deema and Alghamdi Abeer M and Aziz Tariq and Jamal Syed Babar},
  journal = {Open Medicine},
  year = {2026},
  month = oct,
  doi = {10.1515/med-2026-1547},
  url = {https://doi.org/10.1515/med-2026-1547},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Molecular insights into drug repurposing and drug target proteins identification for Yersinia enterocolitica
AU  - Kanwal Munazza
AU  - Bilal Muhammad
AU  - Faheem Muhammad
AU  - Awan Uzma Azeem
AU  - El Hadi Mohamed Rania Ali
AU  - Alwethaynani Maher S.
AU  - Binsaleh Ammena Y.
AU  - Fallatah Deema
AU  - Alghamdi Abeer M
AU  - Aziz Tariq
AU  - Jamal Syed Babar
PY  - 2026
DA  - 2026/10/26
JO  - Open Medicine
DO  - 10.1515/med-2026-1547
UR  - https://doi.org/10.1515/med-2026-1547
AB  - Infectious diseases caused by bacteria such as Yersinia enterocolitica pose significant global health challenges. Y. enterocolitica, a Gram-negative bacterium, is known for causing gastrointestinal diseases in humans. The objective of this study was to identify potential drug targets to combat Y. enterocolitica infections.
SN  - 2391-5463
ER  -